PERALDO NEIA, CATERINA

PERALDO NEIA, CATERINA  

ONCOLOGIA  

Mostra records
Risultati 1 - 11 di 11 (tempo di esecuzione: 0.013 secondi).
Titolo Data di pubblicazione Autore(i) File
Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models. 2014 Peraldo-Neia C;Cavalloni G;Soster M;Gammaitoni L;Marchiò S;Sassi F;Trusolino L;Bertotti A;Medico E;Capussotti L;Aglietta M;Leone F
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer. 2011 Peraldo-Neia C; Migliardi G; Mello-Grand M; Montemurro F; Segir R; Pignochino Y; Cavalloni G; Torchio B; Mosso L; Chiorino G; Aglietta M.
Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient 2016 Cavalloni, Giuliana; Peraldo-Neia, Caterina; Varamo, Chiara; Casorzo, Laura; Dell’Aglio, Carmine; Bernabei, Paola; Chiorino, Giovanna; Aglietta, Massimo; Leone, Francesco
Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation. 2016 Cavalloni G; Peraldo-Neia C; Sassi F; Chiorino G; Sarotto I; Aglietta M; Leone F.
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib 2011 Valabrega G; Capellero S; Cavalloni G; Zaccarello G; Petrelli A; Migliardi G; Milani A; Peraldo-Neia C; Gammaitoni L; Sapino A; Pecchioni C; Moggio A; Giordano S; Aglietta M; Montemurro F.
A new pro-apoptotic therapy for Acute Myeloid Leukaemia using MEDS433, a potent human Dihydroorotate Dehydrogenase inhibitor 2021 Sainas Sainas, Paola Circosta, Noemi Villella, Elena Martino, Agnese Chiara Pippione, Mohammad Houshmand, Marta Giorgis, Valentina Gaidano, Alessandro Cignetti, Caterina Peraldo Neia, Giovanna Chiorino, Salam Al-Karadaghi, Donatella Boschi, Giuseppe Saglio, Marco Lucio Lolli.
Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer 2014 Montemurro F;Prat A;Rossi V;Valabrega G;Sperinde J;Peraldo-Neia C;Donadio M;Galván P;Sapino A;Aglietta M;Baselga J;Scaltriti M
Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma 2016 Cavalloni, Giuliana; Peraldo-Neia, Caterina; Varamo, Chiara; Chiorino, Giovanna; Sassi, Francesco; Aglietta, Massimo; Leone, Francesco
Screening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCR. 2014 Peraldo Neia C;Cavalloni G;Balsamo A;Venesio T;Napoli F;Sassi F;Martin V;Frattini M;Aglietta M;Leone F
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas 2010 Pignochino Y; Sarotto I; Peraldo-Neia C; Penachioni JY; Cavalloni G; Migliardi G; Casorzo L; Chiorino G; Risio M; Bardelli A; Aglietta M; Leone F.
Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma 2018 Peraldo-Neia, C.; Ostano, P.; Cavalloni, G.; Pignochino, Y.; Sangiolo, D.; De Cecco, L.; Marchesi, E.; Ribero, D.; Scarpa, A.; De Rose, A.M.; Giuliani, A.; Calise, F.; Raggi, C.; Invernizzi, P.; Aglietta, M.; Chiorino, G.; Leone, F.